Live Breaking News & Updates on Seanf Scanlan

Stay updated with breaking news from Seanf scanlan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Treace Medical Concepts (NASDAQ:TMCI) PT Lowered to $25.00 at Stephens

Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its target price trimmed by Stephens from $27.00 to $25.00 in a research report sent to investors on Thursday morning, Marketbeat.com reports. The brokerage currently has an equal weight rating on the stock. TMCI has been the topic of a number of other reports. Truist Financial decreased […] ....

United States , Seanf Scanlan , Treace Medical Concepts Inc , Altshuler Shaham Ltd , Td Capital Management , Associates Corp , Securities Exchange Commission , Treace Medical Concepts , Free Report , Moderate Buy , Medical Concepts Stock Down , Medical Concepts , Get Free Report , Treace Medical , Directorf Barry Bays , Exchange Commission , Shaham Ltd , Treace Medical Concepts Daily , Nasdaq Tmci , Lower Price Target ,

Treace Medical Concepts (NASDAQ:TMCI) Trading 2.8% Higher

Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) shares were up 2.8% during mid-day trading on Monday . The stock traded as high as $17.01 and last traded at $17.00. Approximately 62,683 shares were traded during trading, a decline of 84% from the average daily volume of 388,832 shares. The stock had previously closed […] ....

United States , Seanf Scanlan , Td Capital Management , Treace Medical Concepts Company Profile , Securities Exchange Commission , Treace Medical Concepts Inc , Altshuler Shaham Ltd , Associates Corp , Treace Medical Concepts , Get Free Report , Medical Concepts , Directorf Barry Bays , Exchange Commission , Shaham Ltd , Treace Medical Concepts Daily , Nasdaq Tmci ,

Truist Financial Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $30.00

Treace Medical Concepts (NASDAQ:TMCI – Get Free Report) had its price target lowered by investment analysts at Truist Financial from $33.00 to $30.00 in a research note issued on Wednesday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price objective suggests a potential upside of 81.38% from the company’s […] ....

United States , Seanf Scanlan , Swiss National Bank , Treace Medical Concepts Inc , Securities Exchange Commission , Metlife Investment Management , Blackrock Inc , York Mellon Corp , Treace Medical Concepts , Get Free Report , Truist Financial , Medical Concepts Stock Down , Medical Concepts , Treace Medical , Exchange Commission , Directorf Barry Bays , National Bank , New York Mellon Corp , Life Investment Management , Treace Medical Concepts Daily , Nasdaq Tmci , Lower Price Target , Truist Financial Co ,

Treace Medical Concepts (NASDAQ:TMCI) Announces Earnings Results

Treace Medical Concepts (NASDAQ:TMCI – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.20) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.03, Briefing.com reports. Treace Medical Concepts had a negative net margin of 30.48% and a negative return on equity of 48.57%. The firm […] ....

United States , Seanf Scanlan , Jpmorgan Chase Co , Perceptive Advisors , Treace Medical Concepts Inc , Securities Exchange Commission , Ameriprise Financial Inc , Castleark Management , Treace Medical Concepts , Get Free Report , Medical Concepts , Medical Concepts Stock Down , Exchange Commission , Directorf Barry Bays , Treace Medical Concepts Daily , Nasdaq Tmci ,